Clinical Trials
8 trialsNCT01264887 2019-11-04
Tapentadol in Chronic Malignant Tumour Related Pain
Grünenthal GmbH
Phase 3 Terminated
NCT01926444 2019-05-08
A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy
gicare Pharma Inc.
Phase 2 Completed
NCT02578459 2019-02-15
A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain
Flowonix Medical
Phase NA Withdrawn
NCT01152112 2017-09-13
HOME
Hologic, Inc.
Phase NA Completed
NCT02276768 2016-08-10
Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method
gicare Pharma Inc.
Phase 1 Completed
NCT00236041 2014-05-09
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00236327 2011-05-17
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
Janssen Cilag S.A.S.
Phase 4 Terminated
NCT00979342 2010-07-23
Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System
Hologic, Inc.
Phase NA Completed